NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 89 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,801 | -96.6% | 11,029 | -59.2% | 0.00% | -100.0% |
| Q2 2022 | $346,000 | -44.1% | 27,026 | -33.5% | 0.01% | -45.8% |
| Q1 2022 | $619,000 | -17.2% | 40,613 | -3.8% | 0.02% | -29.4% |
| Q4 2021 | $748,000 | +20.8% | 42,210 | +43.3% | 0.03% | -2.9% |
| Q3 2021 | $619,000 | -47.0% | 29,459 | -50.2% | 0.04% | -53.3% |
| Q2 2021 | $1,167,000 | +71.1% | 59,180 | +152.3% | 0.08% | +120.6% |
| Q1 2021 | $682,000 | -33.3% | 23,453 | -30.5% | 0.03% | -22.7% |
| Q4 2020 | $1,022,000 | +45.0% | 33,731 | -23.8% | 0.04% | +33.3% |
| Q3 2020 | $705,000 | -37.9% | 44,292 | -23.0% | 0.03% | -43.1% |
| Q2 2020 | $1,135,000 | +108.6% | 57,506 | +30.2% | 0.06% | +48.7% |
| Q1 2020 | $544,000 | – | 44,153 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |